UCB is a global biopharma focused on severe diseases in two therapeutic areas: central nervous system and immunology operations.
The company is listed on the Euronext Brussels Stock Exchange and has its headquarters in Brussels, Belgium. It employs more than 8,500 people in more than 40 countries.
Financial Data
-
31st Dec 17 Source: CRO
- €163 million turnover
-
€12.2 million
profit - 1 employees
-
31st Dec 16 Source: CRO
- €167.1 million turnover
-
-€10.4 million
profit - 44 employees
- 9 more years available »
Ranking
By Turnover
(€163 million)- 358th in Top Companies
- 39th in Health
- 40th in Pharma
By Employees
(1)- 993rd in Top Companies
- 98th in Health
- 84th in Pharma
-
- 1
- €163 million
Employees
- Steve Turley CEO/Managing Director
Latest News
- Dec 13 Operating profits at INEC owner decrease 7% to €1.32m
- Dec 13 O’Leary told Bellew ‘you are f***ing useless’ in Ryanair meetings, court hears
- Dec 13 Iseq hits 12-year high after UK election result
- Dec 13 Crude oil breaks $65 mark after Opec tightens supplies
- Dec 13 Aston Martin in talks to raise equity capital